Equity analyst Markus Almerud interviews Maha’s CEO Kjetil Solbraekke about the acquisition of 5% of...
Redeye endorses ISAB’s new partnership with the inhalation development service provider Actarmo Medi...
'23e-'25e EBITA down 8-3% Gross margin recovery hampered by Red Sea tensions '24e-'25e lease adj.
On Friday afternoon, 19 January, BankNordik raised its 2023 net profit guidance for the fourth time ...
Q4e: Two deliveries, sales only SEK 3.6m due to payment model '24e the year of e-MELT ID, '25e the y...
Redeye comments on W5’s announcement that it has appointed Evelina Hedskog as new CEO following Dani...
We update our model after recent share issues... ..
Inför Q4: Starkt momentum i onlineaffären kan ge fortsatt bra kanalmix Björn Borgs Q3-rapport prägla...
Duell's results exceeded our estimates for revenue and adj.
Fiskars hosted its CMD event in November and reiterated its financial targets for 2025.
Q4e: sales of SEK 30m, up 37% y-o-y, adj. EBIT SEK -5m (-20m) Turning our eyes to '24e, where we exp...
Q4e: sales SEK 95m, up 16% y-o-y, EBITDA SEK 9m (-4.
Q4e: sales SEK 50m, up +9% q-o-q, EBIT -2m (-4m) Minor estimate changes, eyeing profitable growth in...
Redeye views the waiver of the Finnish loans of EUR6.
Redeye believes the offer from Matrix42 of EUR15 in cash per share is fair, considering the 91% prem...
Acquires ~5% of 3R Petroleum for USD 69m In line with M&A focused growth strategy Proposes several s...
Prostatype Genomics secured SEK 25m in growth capital in the latest right issue.
Redeye comments on Thunderful’s implementation of a restructuring program, which aims to reduce (ann...
Q4e: sales SEK 32m, up 6.4% y-o-y, EBIT margin of 21.
On 15th of January Accendo Capital sold 1.2m shares of Doro in a block trade at SEK18.